Astrazeneca Pharma India Profit & Loss Annual

Trade
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Sector: Major Drugs
8,740.45 -221.50 (-2.47%)Updated : 25 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,295.531,002.97805.60813.56
Total Revenue 1,295.531,002.97805.60813.56
Costof Revenue Total 678.13430.80365.56337.91
Gross Profit 617.40572.17440.04475.65
Selling/ General/ Admin Expenses Total 418.96397.16343.64326.58
Depreciation/ Amortization 14.9416.2616.9520.13
Unusual Expense( Income) -15.1940.23--
Other Operating Expenses Total 12.079.8910.0913.06
Total Operating Expense 1,108.91894.34736.24697.68
Operating Income 186.62108.6369.36115.88
Interest Inc( Exp) Net- Non- Op Total 31.5522.7710.408.83
Gain( Loss)on Saleof Assets 0.032.492.822.17
Other Net 1.340.210.460.21
Net Income Before Taxes 219.54134.1083.04127.09
Provisionfor Income Taxes 58.0334.8121.4433.79
Net Income After Taxes 161.5199.2961.6093.30
Net Income Before Extra Items 161.5199.2961.6093.30
Net Income 161.5199.2961.6093.30
Income Availableto Com Excl Extra Ord 161.5199.2961.6093.30
Income Availableto Com Incl Extra Ord 161.5199.2961.6093.30
Diluted Net Income 161.5199.2961.6093.30
Diluted Weighted Average Shares 2.502.502.502.50
Diluted EPS Excluding Extra Ord Items 64.6039.7224.6437.32
DPS- Common Stock Primary Issue 24.0016.0010.002.00
Diluted Normalized EPS 60.1350.8923.8036.68
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,461.50+15.40(1.06%)
1,480.20+8.90(0.60%)
1,165.30-42.00 (-3.48%)
2,045.35-60.05 (-2.85%)